Simrat Randhawa, Chief Medical Officer: Dianthus Therapeutics DNTH Buy · Filed 23/09/25

Trade details

Type: Insider buy
Amount: $26,400
Shares · price: 2,000 sh · $13.20 a share
Held after: 2,000 sh
Stock: Dianthus Therapeutics DNTH
Person: Simrat RandhawaChief Medical Officer
Trade date: 23/09/21
Filed: 23/09/25
Days to filing: 4 days

4 insiders bought this week

Insiders buying this week: 4 insiders

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/22~23/10/21

Simrat Randhawa's recent trades

Simrat RandhawaEVP, Head of R&D
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$2.4M
23,124 sh
$2.4M
Filed 09/01
Traded 09/01
Simrat RandhawaEVP, Head of R&D
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.5M
16,943 sh
$1.5M
Filed 06/02
Traded 06/01
Simrat RandhawaEVP, Head of R&D
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$487K
5,428 sh
$487K
Filed 06/02
Traded 06/01
Simrat RandhawaEVP, Head of R&D
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$380K
4,159 sh
$380K
Filed 06/02
Traded 06/01
Simrat RandhawaEVP, Head of R&D
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$2.5M
26,530 sh
$2.5M
Filed 06/01
Traded 06/01

Simrat Randhawa, Chief Officer — bought $26.4K of Dianthus Therapeutics DNTH · 2,000 sh @ $13.20 | Whalegun